Recent advances in molecular diagnosis and therapy of gastric cancer

Digestive Diseases

Volumn 22, Issue 4, 2004, Pages 380-385

  Chen, Jie ^a   Röcken, Christoph ^a   Malfertheiner, Peter ^a   Ebert, Matthias P A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric cancer, molecular basis; Gastric cancer, molecular diagnosis; Gastric cancer, molecular therapy

Indexed keywords

4 PHENYLBUTYRIC ACID; 5 AZA 2' DEOXYCYTIDINE; ALKALINE PHOSPHATASE; ANTISENSE OLIGONUCLEOTIDE; CANCER VACCINE; COMPLEMENTARY RNA; CYTOSINE DEAMINASE; CYTOTOXIC AGENT; ENZYME; ETOPOFOS; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FLUCYTOSINE; FLUOROURACIL; FRAGILE HISTIDINE TRIAD PROTEIN; GANCICLOVIR; HAMMERHEAD RIBOZYME; KRESTIN; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; PICIBANIL; PROCAINAMIDE; PRODRUG; PROTEIN P16INK4A; PROTEIN P53; THYMIDINE KINASE; TRICHOSTATIN A; UNINDEXED DRUG; URACIL PHOSPHORIBOSYLTRANSFERASE; UVOMORULIN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; COLON POLYPOSIS; CPG ISLAND; DEATH; DIAGNOSTIC PROCEDURE; DNA HYPERMETHYLATION; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FUNCTIONAL GENOMICS; GENE ACTIVATION; GENE MUTATION; GENE THERAPY; HELICOBACTER PYLORI; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; METASTASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; SUICIDE GENE THERAPY; TRANSCRIPTOMICS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; GENE TRANSFER; GENETICS; METHODOLOGY; ONCOGENE; STOMACH TUMOR;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; ONCOGENES; STOMACH NEOPLASMS;

EID: 21844468556     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083602     Document Type: Review

References (63)

1. Stewart BW, Kleihues P (eds): World Cancer Report. Lyon, IARC Press, 2003.
2. Hamilton SR, Aaltonen LA (eds): Pathology and Genetics. Tumours of the Digestive System. WHO Classification of Tumours. Lyon, IARC Press, 2000. vol 2.
3. Hohenberger P, Gretschel S: Gastric cancer. Lancet 2003;362:305-315.
4. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 1995;333:32-41.
5. Blok P, Craanen ME, Offerhaus GJ, et al: Gastric carcinoma: Clinical, pathogenic, and molecular aspects. QJM 1997;90:735-749.
6. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965;64:31-49.
7. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
8. Nardone G: Review article: Molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 2003;17(suppl 2):75-81.
9. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
10. Murray GI, Duncan ME, Arbuckle E, et al: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998;43:791-797.
11. Sunami T, Yashiro M, Chung KH: ICAM-1 (intercellular adhesion molecule-1) gene transfection inhibits lymph node metastasis by human gastric cancer cells. Jpn J Cancer Res 2000;91:925-933.
12. Kakeji Y, Maehara Y, Sumiyoshi Y, et al: Angiogenesis as a target for gastric cancer. Surgery 2002;131(suppl):48-54.
13. Gulubova MV: Expression of cell adhesion molecules, their ligands and tumour necrosis factor-α in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J 2002;34:67-77.
14. Cameron EE, Bachman KE, Myohanen S, et al: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107.
15. Baylin SB, Esteller M, Rountree MR, et al: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687-692.
16. Esteller M, Herman JG: Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
17. Gaudet F, Hodgson JG, Eden A, et al: Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-492.
18. Eden A, Gaudet F, Waghmare A, et al: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003;300:455.
19. Feinberg AP: Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction. Cancer Res 1999;59(suppl):1743-1746.
20. Esteller M, Corn PG, Baylin SB, et al: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
21. Caldas C, Carneiro F, Lynch HT, et al: Familial gastric cancer: Overview and guidelines for management. J Med Genet 1999;36:873-880.
22. Ebert MP, Malfertheiner P: Review article: Pathogenesis of sporadic and familial gastric cancer - Implications for clinical management and cancer prevention. Aliment Pharmacol Ther 2002;16:1059-1066.
23. Yasui W, Yokozaki H, Shimamoto F, et al: Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology. Pathol Int 1999;49:763-774.
24. Yasui W, Oue N, Kuniyasu H, et al: Molecular diagnosis of gastric cancer: Present and future. Gastric Cancer 2001;4:113-121.
25. Ebert MP, Gunther T, Hoffmann J, et al: Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 2000;60:1995-2001.
26. Kim B, Bang S, Lee S, et al: Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 2003;63:8248-8255.
27. Tay ST, Leong SH, Yu K, et al: A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res 2003;63:3309-3316.
28. Aoyagi K, Tatsuta T, Nishigaki M, et al: A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem Biophys Res Commun 2003;300:915-920.
29. Takenawa H, Kurosaki M, Enomoto N, et al: Differential gene-expression profiles associated with gastric adenoma. Br J Cancer 2004;90:216-223.
30. Oue N, Hamai Y, Mitani Y, et al: Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004;64:2397-2405.
31. Yasui W, Oue N, Ito R, et al: Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004;95:385-392.
32. Sinha P, Poland J, Schnolzer M, et al: Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines. Electrophoresis 2001;22:2990-3000.
33. Tomlinson AJ, Hincapie M, Morris GE, et al: Global proteome analysis of a human gastric carcinoma. Electrophoresis 2002;23:3233-3240.
34. Ryu JW, Kim HJ, Lee YS, et al: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003;18:505-509.
35. Chen JP, Lin C, Xu CP, et al: Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo. J Gastroenterol Hepatol 2001;16:22-28.
36. Song JJ, Lee H, Kim E, et al: Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells. Cancer Lett 2000;157:1-7.
37. Bi F, Fan D, Hui H, et al: Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme. Cancer Gene Ther 2001;8:835-842.
38. Hirao T, Sawada H, Koyama F, et al: Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer. Cancer Gene Ther 1999;6:423-427.
39. Ohashi M, Kanai F, Ueno H, et al: Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut 1999;44:366-371.
40. Jeong YW, Kim KS, Oh JY, et al: Exogenous wild-type p16INK4A gene induces delayed cell proliferation and promotes chemosensitivity through decreased pRB and increased E2F-1 expressions. Int J Mol Med 2003;12:61-65.
41. Ishii H, Zanesi N, Vecchione A, et al: Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J 2003;17:1768-1770.
42. Jung M: Inhibitors of histone deacetylase as new anticancer agents. Curr Med Chem 2001;8:1505-1511.
43. Chiurazzi P, Neri G: Reactivation of silenced genes and transcriptional therapy. Cytogenet Genome Res 2003;100:56-64.
44. Matsuoka T, Yashiro M, Sawada T, et al: Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor. Anticancer Res 2000;20:4331-4338.
45. Matsuoka T, Yashiro M, Sawada T, et al: Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passaged by orthotopic implantation. J Exp Clin Cancer Res 2001;20:213-218.
46. Mori A, Arii S, Furutani M, et al: Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes. Gene Ther 2000;7:1027-1033.
47. Yeo EJ, Chun YS, Cho YS, et al: YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. Natl Cancer Inst 2003;95:516-525.
48. Yang SM, Fang DC, Yang JL, et al: Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma. J Gastroenterol Hepatol 2002;17:1144-1152.
49. Wong SC, Yu H, Moochhala SM, et al: Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells. Anticancer Res 2003;23:465-469.
50. Funato T, Kozawa K, Fujimaki S, et al: Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2) gene. Chemotherapy 2001;47:297-303.
51. Kim R, Minami K, Nishimoto N, et al: Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. Int J Oncol 2001;18:363-367.
52. Stein U, Lage H, Jordan A, et al: Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Int J Cancer 2002;97:751-760.
53. Terazaki Y, Yano S, Yuge K, et al: An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice. Hepatology 2003;37:155-163.
54. Ueda K, Iwahashi M, Nakamori M, et al: Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model. Cancer Res 2001;61:6158-6162.
55. Inaba M, Sawada H, Sadata A, et al: Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction. Jpn J Cancer Res 1999;90:349-354.
56. Kim KY, Cho YJ, Jeon GA, et al: Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells. Mol Cell Biochem 2003;252:213-221.
57. Toge T: Effectiveness of immunochemotherapy for gastric cancer: A review of the current status. Semin Surg Oncol 1999;17:139-143.
58. Watson SA, Gilliam AD: G17DT - A new weapon in the therapeutic armoury for gastrointestinal malignancy. Expert Opin Biol Ther 2001;1:309-317.
59. Kerr C: Promising results in stomach cancer trial. Lancet Oncol 2002;3:523.
60. Guo CC, Ding J, Pan BR, et al: Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated Salmonella typhimurium as carrier. World J Gastroenterol 2003;9:1191-1195.
61. Kono K, Takahashi A, Sugai H, et al: Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Clin Cancer Res 2002;8:3394-3400.
62. Gonzalez G, Crombet T, Catala M, et al: A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial. Ann Oncol 1998;9:431-435.
63. Chen J, Chen MH, Röcken C, et al: Molecular therapy of gastric cancer. Cancer Therapy 2003;1:323-333.